Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 410–412 | Cite as

A case of cutaneous angiosarcoma successfully treated with eribulin

  • Kazuma Iwamoto
  • Yasuhiro Fujisawa
  • Yousuke Ishitsuka
  • Hiroshi Maruyama
  • Yoshiyuki Nakamura
  • Naoko Okiyama
  • Rei Watanabe
  • Manabu Fujimoto
Correspondence

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tsuchida T, Hiroshi K, Uhara H, et al. Guideline for cutaneous malignancies, version 2. Jpn J Dermatol 2015; 125: 5–75.Google Scholar
  2. 2.
    Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma:update on biology and latest treatment. Curr Opin Oncol 2018; 30: 107–12.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Kawai A, Yonemori K, Takahashi S, Araki N, Ueda T. Systemic therapy for soft tissue sarcoma:proposals for the optimal use of pazopanib, trabectedin, and eribulin. Adv Ther 2017; 34: 1556–71.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Jordan MA, Kamath K, Manna T, et al. The primary antimitotic mechanism of action of the synthetic halichondrin e7389 is suppression of microtubule growth. Mol Cancer Ther 2005; 4: 1086–95.CrossRefPubMedGoogle Scholar
  5. 5.
    Mani S, Swami U. Eribulin mesilate, a halichondrin b analogue, in the treatment of breast cancer. Drugs Today (Barc) 2010; 46: 641–53.CrossRefGoogle Scholar
  6. 6.
    Schoffski P, Chawla S, Maki RG, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma:a randomised, open–label, multicentre, phase 3 trial. Lancet 2016; 387: 1629–37.CrossRefPubMedGoogle Scholar
  7. 7.
    Schoffski P, Ray–Coquard IL, Cioffi A, et al. Activity of eribulin mesylate in patients with soft–tissue sarcoma:a phase 2 study in four independent histological subtypes. Lancet Oncol 2011; 12: 1045–52.CrossRefPubMedGoogle Scholar
  8. 8.
    Wada N, Uchi H, Furue M. Case of angiosarcoma of the scalp successfully controlled by eribulin. J Dermatol 2018; 45: 116–7.CrossRefPubMedGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Kazuma Iwamoto
    • 1
  • Yasuhiro Fujisawa
    • 1
  • Yousuke Ishitsuka
    • 1
  • Hiroshi Maruyama
    • 1
  • Yoshiyuki Nakamura
    • 1
  • Naoko Okiyama
    • 1
  • Rei Watanabe
    • 1
  • Manabu Fujimoto
    • 1
  1. 1.Department of DermatologyUniversity of TsukubaTsukubaJapan

Personalised recommendations